Improved Management of Patients With Recent-Onset Stable Chest Pain
Recruiting
N/A
Interventional Study
Coronary Artery Disease (CAD)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 30 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 3,369 (estimated)
- Sponsor
- Philipps University Marburg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
In Germany, coronary CT offers an accurate and less burdensome alternative to cardiac catheterisation for evaluating suspected coronary artery disease, but it is still underused. The IMPRO stepped-wedge trial tests a new, nationwide care model (NVF) in 16 regions to improve guideline-based intersectoral implementation of coronary CT and assess its impact on cardiovascular outcomes and healthcare c…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥30 years
* Suspected CAD with stable chest pain
* Ability to give informed consent
Exclusion Criteria:
* Known or previously treated (with PCI or CABG) obstructive CAD (defined as at least one coronary diameter stenosis ≥50%)
* Acute coronary syndrome
* Negative invasiv…
Contacts
Marc Dewey, Prof. Dr.
CONTACT